Stay updated with breaking news from Nasdaq Inmb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fermata Advisors LLC bought a new stake in shares of INmune Bio, Inc. (NASDAQ:INMB – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 56,702 shares of the company’s stock, valued at approximately $384,000. A number of other […]
INmune Bio (NASDAQ:INMB – Get Free Report) and Mesoblast (NASDAQ:MESO – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Volatility & Risk INmune Bio has a beta […]
Company to Host Conference Call Today, November 1, at 4:30pm ET...
MAI Capital Management lifted its position in shares of INmune Bio, Inc. (NASDAQ:INMB – Free Report) by 201.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,177 shares of the company’s stock after purchasing an additional 39,534 shares during the period. MAI […]
MAI Capital Management raised its stake in shares of INmune Bio, Inc. (NASDAQ:INMB – Free Report) by 201.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,177 shares of the company’s stock after purchasing an additional 39,534 shares during the […]